"TBSF" (20%) Human Albumin Solution

Maa: Australia

Kieli: englanti

Lähde: Department of Health (Therapeutic Goods Administration)

Aktiivinen ainesosa:

Albumin, Quantity: 200 g/L

Saatavilla:

CSL Behring Australia Pty Ltd

INN (Kansainvälinen yleisnimi):

Albumin

Lääkemuoto:

Injection, solution

Koostumus:

Excipient Ingredients: octanoate; sodium

Antoreitti:

Intravenous

Kpl paketissa:

50mL, 100mL

luokka:

Medicine Listed (Export Only)

Prescription tyyppi:

(S1) This Schedule is intentionally blank

Käyttöaiheet:

Hypoproteinaemia in the acutely ill patient TBSF (20%) Human Albumin Solution is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. Shock. TBSF (20%) Human Albumin Solution may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. Burns. Extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

Tuoteyhteenveto:

Visual Identification: Clear, slightly viscous almost colourless, yellow or green; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

Valtuutuksen tilan:

Listed (Export Only)

Valtuutus päivämäärä:

2006-03-01